...
首页> 外文期刊>Cancer Cell International >Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design
【24h】

Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design

机译:ZFN和TALEN对癌基因的基因组编辑:核酸酶设计的注意事项

获取原文
           

摘要

Gene knockout technologies involving programmable nucleases have been used to create knockouts in several applications. Gene editing using Zinc-finger nucleases (ZFNs), Transcription activator like effectors (TALEs) and CRISPR/Cas systems has been used to create changes in the genome in order to make it non-functional. In the present study, we have looked into the possibility of using six fingered CompoZr ZFN pair to target the E6 gene of HPV 16 genome. HPV 16+ve cell lines; SiHa and CaSki were used for experiments. CompoZr ZFNs targeting E6 gene were designed and constructed by Sigma-Aldrich. TALENs targeting E6 and E7 genes were made using TALEN assembly kit. Gene editing was monitored by T7E1 mismatch nuclease and Nuclease resistance assays. Levels of E6 and E7 were further analyzed by RT-PCR, western blot as well as immunoflourescence analyses. To check if there is any interference due to methylation, cell lines were treated with sodium butyrate, and Nocodazole. Although ZFN editing activity in yeast based MEL-I assay was high, it yielded very low activity in tumor cell lines; only 6% editing in CaSki and negligible activity in SiHa cell lines. Though editing efficiency was better in CaSki, no significant reduction in E6 protein levels was observed in immunocytochemical analysis. Further, in silico analysis of DNA binding prediction revealed that some of the ZFN modules bound to sequence that did not match the target sequence. Hence, alternate ZFN pairs for E6 and E7 were not synthesized since no further active sites could be identified by in silico analyses. Then we designed TALENs to target E6 and E7 gene. TALENs designed to target E7 gene led to reduction of E7 levels in CaSki and SiHa cervical cancer cell lines. However, TALEN designed to target E6 gene did not yield any editing activity. Our study highlights that designed nucleases intended to obtain bulk effect should have a reasonable editing activity which reflects phenotypically as well. Nucleases with low editing efficiency, intended for generation of knockout cell lines nucleases could be obtained by single cell cloning. This could serve as a criterion for designing ZFNs and TALENs.
机译:涉及可编程核酸酶的基因敲除技术已用于在多种应用中产生敲除。使用锌指核酸酶(ZFN),转录激活子样效应子(TALE)和CRISPR / Cas系统进行基因编辑已在基因组中产生变化,以使其无功能。在本研究中,我们研究了使用六指的CompoZr ZFN对靶向HPV 16基因组E6基因的可能性。 HPV 16 + ve细胞系; SiHa和CaSki用于实验。靶向E6基因的CompoZr ZFN由Sigma-Aldrich设计和构建。使用TALEN组装试剂盒制备靶向E6和E7基因的TALEN。通过T7E1错配核酸酶和核酸酶抗性试验监测基因编辑。通过RT-PCR,蛋白质印迹和免疫荧光分析进一步分析E6和E7的水平。为了检查是否存在由于甲基化引起的干扰,用丁酸钠和诺考达唑处理了细胞系。尽管在基于酵母的MEL-I分析中ZFN编辑活性很高,但在肿瘤细胞系中却产生非常低的活性。 CaSki中只有6%的编辑,而SiHa细胞系中的活性却微不足道。尽管在CaSki中编辑效率更好,但是在免疫细胞化学分析中未观察到E6蛋白水平的显着降低。此外,对DNA结合预测的计算机分析表明,某些ZFN模块结合了与靶序列不匹配的序列。因此,未合成用于E6和E7的ZFN对,因为无法通过计算机分析识别出更多的活性位点。然后我们设计了TALENs以靶向E6和E7基因。设计用于靶向E7基因的TALENs导致CaSki和SiHa宫颈癌细胞株中E7水平降低。但是,针对E6基因设计的TALEN没有产生任何编辑活性。我们的研究强调,旨在获得整体效应的设计核酸酶应具有合理的编辑活性,该活性也应反映表型。可通过单细胞克隆获得旨在产生敲除细胞系核酸酶的,编辑效率低的核酸酶。这可以作为设计ZFN和TALEN的标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号